Therapeutic or Preventive Procedure

Eli Lilly; Lilly; Ventyx Biosciences; InduPro; inflammatory diseases; oncology; NLRP3 inhibitors; tamuzimod; VTX2735; VTX3232; VTX958; autoimmune; obesity; cardiometabolic; neuroinflammation; M&A; biotech deal; cancer immunotherapy

Independent expert group to review HPV vaccine evidence after US recommendation change

7 days ago talkbio0Tagged ACIP, CDC, Centers for Disease Control and Prevention (U.S.), Childhood, CIDRAP, disbanded, Gardasil, HPV vaccine, Immunization Schedule, independent review, recommendation change, single-dose schedule, U.S., Vaccine Integrity Project

HPV vaccine; Vaccine Integrity Project; independent review; CDC recommendation change; single-dose schedule; ACIP disbanded; CIDRAP; Robert F. Kennedy Jr.; US childhood immunization schedule; Gardasil

Relation and Deerfield form NewCos to develop drugs from AI-discovered targets

1 week ago talkbio0Tagged AI drug discovery, Bone Diseases, Deerfield Management, Drug Delivery Systems, Immunology, Lab-in-the-Loop, Metabolic Diseases, newco, Platform, Relative (related person), royalties, strategic collaboration

Relation; Deerfield Management; strategic collaboration; NewCo; AI drug discovery; Lab-in-the-Loop platform; novel therapeutics; immunology; metabolic disease; bone disease; drug targets; royalties

Rakuten Medical Raises $100 Million in Oversubscribed Series F for Photoimmunotherapy Platform

1 week ago talkbio0Tagged Alluminox, Cancer Therapeutic Procedure, methionine, Photoimmunotherapy, Rakuten Medical, regulatory approval, Series F

Rakuten Medical; Series F; $100M; photoimmunotherapy; cancer therapy; Alluminox; regulatory approval

FDA Memo Claims COVID Vaccine Linked to 10 Child Deaths, Faces Expert Skepticism and Criticism

1 week ago talkbio0Tagged COVID, Death of child, MEMO1 gene, United States Food and Drug Administration, Vaccine Safety, Vaccines, VAERS, Vinay Prasad

FDA memo; COVID vaccine; child deaths; Vinay Prasad; VAERS; vaccine safety

Bayer Receives Breakthrough Therapy Designation in US and China for Sevabertinib in First-Line HER2-Mutant NSCLC

1 week ago talkbio0Tagged Bayer, Breakthrough Therapy Designation, CDE, China, First line treatment, HER2-mutant, Non-Small Cell Lung Carcinoma, sevabertinib, United States Food and Drug Administration

Bayer; sevabertinib; Breakthrough Therapy Designation; HER2-mutant NSCLC; FDA; China CDE; first-line treatment

Spotlight On: Five key oncology stories to watch in 2026

1 week ago talkbio0Tagged 2026, Antibody-Drug Conjugates, cancer research trends, CAR-T, Cell Therapy, Liquid Biopsy, Lymphocytes, Tumor-Infiltrating, mRNA cancer, Neoplasms, oncology decisions, precision oncology, Radiopharmaceuticals, T-Cell Receptor, United States Food and Drug Administration, Vaccines

oncology 2026; cancer research trends; FDA oncology decisions 2026; antibody-drug conjugates; radiopharmaceuticals; liquid biopsy; mRNA cancer vaccines; AI in oncology; cell therapies CAR-T TIL TCR; precision oncology